GW Pharma raising $180m
This article was originally published in Scrip
Executive Summary
GW Pharmaceuticals, which develops therapeutics using its cannabinoid product platform, is raising $179.2m through the placement of 1,600,000 American Depositary Shares (ADSs), priced at $112per ADS on the Nasdaq Global Market.